Stacy Scheehle
Tetragon Partners Gp Ltd
Assets Managed
$515.115M
Holdings
34
Last Quarter
2026 - Q1
Filed Date
15d ago
Growth Rate
8.62%(2Q avg: -13.97%)
Sustained Growth
1 quarters
Portfolio positions
This chart displays the top 10 holdings in Tetragon Partners Gp Ltd's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 34 positions.
Assets under management
The assets under management (AUM) of Tetragon Partners Gp Ltd over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 515.115M in assets, with a quarterly growth rate of 8.62% and a 2-quarter average growth rate of -13.97%. The portfolio is managed by Stacy Scheehle, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
PATH Uipath Inc - Class A
| 54.32% | $279.805M 25.208M shares@ $11.11 avg price | Increased 44.46% |
KGEI Kolibri Global Energy Inc
| 7.29% | $37.521M 6.835M shares@ $5.5 avg price | Decreased -1.44% |
WBD Warner Bros Discovery Inc
| 4.93% | $25.365M 923,725 shares@ $27.47 avg price | New Position |
WK Workiva Inc
| 2.9% | $14.908M 250,000 shares@ $59.63 avg price | Increased 66.67% |
LYFT Lyft Inc-a
| 2.59% | $13.3M 1M shares@ $13.3 avg price | |
CXM Sprinklr Inc-a
| 2.57% | $13.2M 2.2M shares@ $6.0 avg price | |
AUTL Autolus Therapeutics Plc
| 2.55% | $13.11M 9.5M shares@ $1.38 avg price | |
CLDX Celldex Therapeutics Inc
| 1.93% | $9.907M 312,316 shares@ $31.73 avg price | Increased 28.11% |
AXSM Axsome Therapeutics Inc
| 1.81% | $9.306M 55,059 shares@ $169.02 avg price | Increased 104.43% |
ARWR Arrowhead Pharmaceuticals In
| 1.55% | $7.975M 127,198 shares@ $62.71 avg price | Increased 31.22% |
1-10 of 34